Researchers at the Technical University of Munich (TUM) have developed a system that helps patients learn to move their ...

LFWD secures FDA clearance for its ReWalk 7 Exoskeleton, introducing enhanced features to empower individuals with spinal cord injury and expand mobility options.

Read a a detailed recap of the 2024 Dead & Company residency at Sphere ahead of the Grateful Dead offshoot's 2025 'Dead ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a ...

Lifeward announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk ...

FDA clearance for the newest generation of its personal exoskeleton device, the ReWalk 7. The seventh generation of the ReWalk, a wearable exoskeleton that allows individuals with spinal cord injury ...

The device straps on top of a pianist’s hand, with small motors attached to each finger. It can move each finger ...

This requires targeted stimulation of the muscles in the forearm and the support of an exoskeleton. Twenty-four stroke patients have already tested the system at the Schön Klinik Bad Aibling. The ...

CorLife to become the exclusive distributor of the ReWalk Personal Exoskeleton for individuals with Workers’ Compensation ...

Lifeward stock is trading higher on Thursday after the company announced that its ReWalk 7 received 510(k) clearance from the ...

CorLife, a division of Numotion, has become the exclusive distributor for Lifeward’s ReWalk Personal Exoskeleton for people with workers’ compensation claims.

The seventh generation of the ReWalk, a wearable exoskeleton that allows individuals with spinal cord injury (SCI) to stand and walk again, includes a number of new features, as well as ...